Prof. Sultan Abu-Orabi

Professor Sultan Abu-Orabi received his PhD in Organic Chemistry from University of Michigan, Ann Arbor, USA in 1982, his MSc in Chemistry from Western Michigan University, USA in 1977, and his BSc in Chemistry from University of Jordan, Jordan in 1973. He was President of Yarmouk University, Jordan, in the period 2009-2011, President of Tafila Technical University, Jordan, 2005-2009, President of Irbid National University, Jordan, 2002–2005 and was elected Secretary General of Association of Arab Universities in July 2011. Professor Sultan Abu-Orabi was also President of Arab Union of Chemists, Secretary General of Arab Union of Chemists and President of Jordanian Chemical Society, 2000-present. He has published over 125 papers and 5 books.

Invited Lectures

Selective Ligands for Actinide-Lanthanide Separations
Design, Synthesis, And Pharmacological Properties Of New Cb₂ Cannabinoid Receptor Ligands
Novel Rearrangements in Targeted Synthesis of Natural Compound Analogs
Nef-Isocyanide Adducts as key Intermediates for Synthesis of Heterocyclic Compounds
Multicomponent 1,3-Dipolar Cycloadditions of Stabilized Azomethine Ylides
Discovering new applications of chiral N-sulfinyl imines in heterocyclic chemistry
Aliphatic Nitrocompounds as Strategic Sources of Heterocycles
Synthetic Strategies for New Pyrazoles of Potential Biological Activities
Enaminones in the synthesis of heterocyclic systems. [2+2] Cycloadditions, ring expansion reactions and other transformations
Design, synthesis and pharmacological properties of new thiazole and thiadiazole derivatives
Cultivating over thirty years the passion to build heterocycles from 1,2-diaza-1,3-dienes
[1,4]Thiazino[3,4-c][1,2,4]oxadiazol-3-ones: an examination of their reactivity and of their biological profile
Effective Conversion of Carbohydrate Molecules to Nitrogen-containing Heterocyclic Derivatives
Recent Advances in Appel Salt Chemistry
Heterocyclic compounds in the design of biodegradable polymers
Synthesis and study of some triazolo Isoxazole heterocyclic Compounds
Three different approaches to target the T315I mutation: ATP-competitive, ATP-non-competitive and 14-3-3 inhibitors
Tetrapyrrolic macrocycles: Synthetic features and potential applications
Reactivity of alpha-halogen substituted pyridinium ylides.
Benzopyran building blocks: herald of hope for multitarget drug discovery
A new general 3CR leading to 1,4,5-trisubstituted-1,2,3-triazoless
Marine alkaloid nortopsentin analogues inhibitors of cyclin-dependent kinase 1 (CDK1)